These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2680377)

  • 1. Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons.
    Sayer JM; Whalen DL; Jerina DM
    Drug Metab Rev; 1989; 20(2-4):155-82. PubMed ID: 2680377
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
    Adams SM; Kaminsky LS
    Mol Pharmacol; 1982 Sep; 22(2):459-64. PubMed ID: 7144738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
    Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K
    Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically-active and chemically-reactive polycyclic hydrocarbon metabolites.
    Phillips DH; Grover PL
    IARC Sci Publ; 1984; (59):47-61. PubMed ID: 6545297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
    Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
    Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts.
    Day BW; Naylor S; Gan LS; Sahali Y; Nguyen TT; Skipper PL; Wishnok JS; Tannenbaum SR
    Cancer Res; 1990 Aug; 50(15):4611-8. PubMed ID: 2369737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural factors that enhance or attenuate the carcinogenicity of polycyclic aromatic hydrocarbons.
    Yang SK
    Prog Clin Biol Res; 1983; 132B():151-60. PubMed ID: 6634752
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactions of polycyclic aromatic hydrocarbons with DNA.
    Dipple A
    IARC Sci Publ; 1994; (125):107-29. PubMed ID: 7806307
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenicity of methylated hydrocarbons: effect of methylation on the calculated diol-epoxide reactivity.
    Silverman BD; Lowe JP
    Cancer Biochem Biophys; 1982; 6(2):89-94. PubMed ID: 7151036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between carcinogenicity and theoretical reactivity indices in polycyclic aromatic hydrocarbons.
    Smith IA; Berger GD; Seybold PG; Servé MP
    Cancer Res; 1978 Sep; 38(9):2968-77. PubMed ID: 679205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons.
    Slaga TJ; Gleason GL; Mills G; Ewald L; Fu PP; Lee HM; Harvey RG
    Cancer Res; 1980 Jun; 40(6):1981-4. PubMed ID: 7371034
    [No Abstract]   [Full Text] [Related]  

  • 13. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adducts of nitropolycyclic aromatic hydrocarbons.
    Beland FA; Marques MM
    IARC Sci Publ; 1994; (125):229-44. PubMed ID: 7806315
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic activation of polycyclic aromatic carcinogens: a theoretical study.
    Umans RS; Koruda M; Sardella DJ
    Mol Pharmacol; 1979 Sep; 16(2):633-42. PubMed ID: 514263
    [No Abstract]   [Full Text] [Related]  

  • 16. A molecular orbital treatment on the reactivity of some polycyclic aromatic hydrocarbon diol-epoxides.
    Imamura A; Ohsaku M
    J Theor Biol; 1983 Jun; 102(4):511-9. PubMed ID: 6413785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity of dihydrodiols and diol-epoxides of benz[c]acridine in newborn mice.
    Chang RL; Levin W; Wood AW; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1984 Nov; 44(11):5161-4. PubMed ID: 6488176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens.
    Levin W; Wood A; Chang R; Ryan D; Thomas P; Yagi H; Thakker D; Vyas K; Boyd C; Chu SY; Conney A; Jerina D
    Drug Metab Rev; 1982; 13(4):555-80. PubMed ID: 6290166
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation, metabolism, and mechanism of action of polycyclic aromatic hydrocarbons.
    Dipple A
    Cancer Res; 1983 May; 43(5 Suppl):2422s-2425s. PubMed ID: 6403235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of epoxides and epoxy compounds.
    Hemminki K; Vainio H
    Prog Clin Biol Res; 1984; 141():373-84. PubMed ID: 6718385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.